We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.75%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.69B
AUM Growth
-$542M
Cap. Flow
-$781M
Cap. Flow %
-21.18%
Top 10 Hldgs %
56.86%
Holding
480
New
156
Increased
61
Reduced
86
Closed
113

Top Buys

Rank Stock Value
1
SKX
Skechers
SKX
+$207M
2
BPMC
Blueprint Medicines
BPMC
+$176M
3
WBA
Walgreens Boots Alliance
WBA
+$167M
4
DNB
Dun & Bradstreet
DNB
+$122M
5
INFA
Informatica
INFA
+$93.8M

Top Sells

Rank Stock Value
1
DFS
Discover Financial Services
DFS
+$408M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$408M
3
HES
Hess
HES
+$251M
4
BECN
Beacon Roofing Supply, Inc.
BECN
+$195M
5
BERY
Berry Global Group, Inc.
BERY
+$137M

Sector Composition

Rank Sector Weight
1 Healthcare 19.77%
2 Technology 14.28%
3 Consumer Staples 10.98%
4 Energy 9.87%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CC icon
251
PUT
Chemours
CC
$2.3B
$638K 0.02%
46,900
– –
SPY icon
252
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$628K 0.02%
190,500
+105,500
+124% +$60.3M
BBIO icon
253
BridgeBio Pharma
BBIO
$14.6B
$595K 0.02%
13,771
-11,721
-46% -$426K
UWMC icon
254
UWM Holdings
UWMC
$2.36B
$592K 0.02%
143,000
– –
TMCI icon
255
Treace Medical Concepts
TMCI
$313M
$590K 0.02%
100,317
-47,378
-32% -$309K
VISN
256
CALL
Vistance Networks Inc
VISN
$1.48B
$578K 0.02%
550,000
+100,000
+22% +$523K
CEPT
257
DELISTED
Cantor Equity Partners II
CEPT
$552K 0.02%
+50,000
New +$565K
NUVB icon
258
Nuvation Bio
NUVB
$2.39B
$551K 0.01%
282,464
-309,655
-52% -$645K
SBXD
259
SilverBox Corp IV
SBXD
$548K 0.01%
50,000
-192,175
-79% -$2.01M
MBLY icon
260
Mobileye
MBLY
$7.28B
$539K 0.01%
+30,000
New +$458K
NGNE icon
261
Neurogene
NGNE
$772M
$520K 0.01%
34,761
-21,254
-38% -$334K
KROS icon
262
Keros Therapeutics
KROS
$224M
$506K 0.01%
37,891
-77,627
-67% -$1.05M
ORIC icon
263
Oric Pharmaceuticals
ORIC
$1.33B
$497K 0.01%
49,000
+1,358
+3% +$9.12K
SDGR icon
264
Schrodinger
SDGR
$1.5B
$490K 0.01%
24,358
-34,685
-59% -$792K
MGM icon
265
PUT
MGM Resorts International
MGM
$10.4B
$452K 0.01%
82,600
– –
TARS icon
266
Tarsus Pharmaceuticals
TARS
$3.98B
$446K 0.01%
+11,000
New +$495K
RLAY icon
267
Relay Therapeutics
RLAY
$4.17B
$440K 0.01%
127,036
-255,864
-67% -$761K
RCUS icon
268
Arcus Biosciences
RCUS
$3.78B
$431K 0.01%
52,975
-75,713
-59% -$647K
CHTR icon
269
PUT
Charter Communications
CHTR
$18.1B
$383K 0.01%
20,500
– –
ARVN icon
270
Arvinas
ARVN
$614M
$368K 0.01%
+50,000
New +$368K
HLF icon
271
PUT
Herbalife
HLF
$1.3B
$354K 0.01%
82,400
– –
FOUR icon
272
CALL
Shift4
FOUR
$3.63B
$354K 0.01%
+35,000
New +$3.05M
SABR icon
273
Sabre
SABR
$860M
$348K 0.01%
+110,000
New +$282K
MRVL icon
274
CALL
Marvell Technology
MRVL
$201B
$341K 0.01%
+75,000
New +$4.68M
REPL icon
275
CALL
Replimune Group
REPL
$1.42B
$308K 0.01%
+169,000
New +$1.47M
9 10
11
12 13

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2025 Portfolio in Review

As of Q2 2025, UBS O'Connor held 480 positions worth $3.69B, down 13% from $4.23B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

UBS O'Connor withdrew a net $781M in Q2 2025, closing 113 positions and reducing 86 holdings. Its most notable exit was Discover Financial Services, an estimated $408M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, UBS O'Connor opened a new position in Skechers worth $227M.

  • UBS O'Connor's largest Q2 2025 buy was Skechers: 3,598,177 shares worth $227M.
  • UBS O'Connor added most to Blueprint Medicines in Q2 2025, an estimated $176M increase.
  • UBS O'Connor's biggest Q2 2025 reduction was Hess, cutting an estimated $251M.
  • UBS O'Connor fully exited Discover Financial Services in Q2 2025, selling an estimated $408M.
  • UBS O'Connor's ten largest holdings make up 57% of its $3.69B portfolio in Q2 2025.
  • UBS O'Connor opened 156 new positions and closed 113 in Q2 2025.
  • UBS O'Connor's portfolio value fell 13% quarter-over-quarter to $3.69B.

Based on UBS O'Connor's 13F filing for Q2 2025, filed 14 Aug 2025.